Traders work on the floor of the New York Stock Exchange (NYSE) shortly after the opening bell in New York, U.S., October 17, 2016.REUTERS/Lucas Jackson
The S&P and the Nasdaq were on track for their best day this month on Tuesday as a slew of market-beating results from marquee companies boosted optimism about Corporate America’s health.
The spotlight was on the healthcare sector .SPXHC, which rose 1.04 percent, the most in more than one month, after UnitedHealth’s (UNH.N) upbeat forecast. UnitedHealth rose 6.3 percent and boosted its fellow health insurers.
Netflix (NFLX.O), which dragged on the market on Monday ahead of its results, was the biggest gainer on the S&P 500 on Tuesday, rising nearly 19 percent after posting much higher-than-expected subscriber growth.
Goldman Sachs (GS.N) rose 2.2 percent, lifting shares of other banks, after the company’s results blew past Wall Street estimates, mirroring results at its Wall Street peers.
Of the 37 S&P 500 companies that have reported results until Monday, 78 percent have reported earnings that have topped analysts average estimate, according to Thomson Reuters I/B/E/S.
Analysts now estimate earnings of S&P companies slipped 0.1 percent in the third quarter, less than their earlier estimate of a drop of 0.7 percent, raising hopes that a four-quarter streak of negative earnings growth could be snapped.
“We’re seeing the delta improve to the upside in this earnings season and that sets the tone for the fourth quarter performance,” said Terry Sandven, chief equity strategist at U.S. Bank Wealth Management in Minneapolis.
At 11:08 a.m. EDT, the Dow Jones Industrial Average .DJI was up 77.49 points, or 0.43 percent, at 18,163.89.
Even economic data helped boost sentiment. U.S. consumer prices recorded their biggest gain in five months in September, pointing to a steady build-up of inflation that could keep the Federal Reserve on track to raise interest rates in December.
“The economy continues to show signs of improvement, with the CPI data showing that there are signs of a modest level of inflation creeping into the marketplace,” Sandven said.
Nine of the 11 major S&P 500 sectors were higher, with only the interest rate-sensitive utilities .SPLRCU and telecom services .SPLRCL in the red.
Among the laggards was IBM (IBM.N), which fell 3.3 percent after reporting its 18th straight quarter of revenue decline.
Johnson & Johnson (JNJ.N) was down 2.4 percent, while Pfizer (PFE.N) gained 0.8 percent on after it announced plans to ship a cheaper biosimilar to Remicade, JNJ’s top selling product. The news overshadowed J&J’s slight earnings beat.
Advancing issues outnumbered decliners on the NYSE by 2,199 to 656. On the Nasdaq, 1,797 issues rose and 788 fell.
The S&P 500 index showed three new 52-week highs and one new lows, while the Nasdaq recorded 32 new highs and 38 new lows.
(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Savio D’Souza)